1hy7
From Proteopedia
| Line 4: | Line 4: | ||
|PDB= 1hy7 |SIZE=350|CAPTION= <scene name='initialview01'>1hy7</scene>, resolution 1.5Å | |PDB= 1hy7 |SIZE=350|CAPTION= <scene name='initialview01'>1hy7</scene>, resolution 1.5Å | ||
|SITE= | |SITE= | ||
| - | |LIGAND= | + | |LIGAND= <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=MBS:R-2-{[4'-METHOXY-(1,1'-BIPHENYL)-4-YL]-SULFONYL}-AMINO-6-METHOXY-HEX-4-YNOIC+ACID'>MBS</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene> |
| - | |ACTIVITY= [http://en.wikipedia.org/wiki/Stromelysin_1 Stromelysin 1], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.24.17 3.4.24.17] | + | |ACTIVITY= <span class='plainlinks'>[http://en.wikipedia.org/wiki/Stromelysin_1 Stromelysin 1], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.24.17 3.4.24.17] </span> |
|GENE= MMP3 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens]) | |GENE= MMP3 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens]) | ||
| + | |DOMAIN= | ||
| + | |RELATEDENTRY=[[1g49|1G49]], [[1cqr|1CQR]], [[1d5j|1D5J]], [[1d7x|1D7X]], [[1d8f|1D8F]], [[1d8m|1D8M]] | ||
| + | |RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1hy7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1hy7 OCA], [http://www.ebi.ac.uk/pdbsum/1hy7 PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1hy7 RCSB]</span> | ||
}} | }} | ||
| Line 16: | Line 19: | ||
==Disease== | ==Disease== | ||
| - | Known | + | Known disease associated with this structure: Coronary heart disease, susceptibility to OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=185250 185250]] |
==About this Structure== | ==About this Structure== | ||
| Line 44: | Line 47: | ||
[[Category: Pikul, S.]] | [[Category: Pikul, S.]] | ||
[[Category: Pokross, M E.]] | [[Category: Pokross, M E.]] | ||
| - | [[Category: CA]] | ||
| - | [[Category: MBS]] | ||
| - | [[Category: ZN]] | ||
[[Category: inhibited]] | [[Category: inhibited]] | ||
[[Category: mixed alpha beta structure]] | [[Category: mixed alpha beta structure]] | ||
[[Category: zinc protease]] | [[Category: zinc protease]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Mar | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Mar 30 21:11:57 2008'' |
Revision as of 18:11, 30 March 2008
| |||||||
| , resolution 1.5Å | |||||||
|---|---|---|---|---|---|---|---|
| Ligands: | , , | ||||||
| Gene: | MMP3 (Homo sapiens) | ||||||
| Activity: | Stromelysin 1, with EC number 3.4.24.17 | ||||||
| Related: | 1G49, 1CQR, 1D5J, 1D7X, 1D8F, 1D8M
| ||||||
| Resources: | FirstGlance, OCA, PDBsum, RCSB | ||||||
| Coordinates: | save as pdb, mmCIF, xml | ||||||
A CARBOXYLIC ACID BASED INHIBITOR IN COMPLEX WITH MMP3
Contents |
Overview
A series of carboxylic acids were prepared from a propargylglycine scaffold and tested for efficacy as matrix metalloproteinase (MMP) inhibitors. Detailed SAR for the series is reported for four enzymes within the MMP family. The inhibitors were typically potent against collagenase-3 (MMP-13) and gelatinase A (MMP-2), while they spared collagenase-1 (MMP-1) and only moderately inhibited stromelysin (MMP-3). Compound 40 represents a typical inhibition profile of a compound with reasonable potency. Introduction of polar groups was required in order to generate inhibitors with acceptable water solubility, and this often resulted in a loss of potency as in compound 63. High serum protein binding proved to be a difficult hurdle with many compounds such as 48 showing >99% binding. Some compounds such as 64 displayed approximately 90% binding, but no reliable method was discovered for designing molecules with low protein binding. Finally, selected data regarding the pharmacokinetic behavior of these compounds is presented.
Disease
Known disease associated with this structure: Coronary heart disease, susceptibility to OMIM:[185250]
About this Structure
1HY7 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines., Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE, J Med Chem. 2001 Mar 29;44(7):1060-71. PMID:11297453
Page seeded by OCA on Sun Mar 30 21:11:57 2008
Categories: Homo sapiens | Single protein | Stromelysin 1 | Almstead, N G. | Baker, T R. | Bookland, R G. | Branch, T M. | De, B. | Foltz, D J. | Garver, S M. | Gu, F. | Hsieh, L C. | Janusz, M J. | King, S L. | Laufersweiler, M J. | Mieling, G E. | Natchus, M G. | Patel, V S. | Peng, S X. | Pikul, S. | Pokross, M E. | Inhibited | Mixed alpha beta structure | Zinc protease
